These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Factors associated with proximal carotid axis occlusion in patients with acute stroke and atrial fibrillation. Sakamoto Y; Sato S; Kuronuma Y; Nagatsuka K; Minematsu K; Toyoda K J Stroke Cerebrovasc Dis; 2014; 23(5):799-804. PubMed ID: 24103668 [TBL] [Abstract][Full Text] [Related]
25. Determinants of plasma levels of brain natriuretic peptide after acute ischemic stroke or TIA. Di Angelantonio E; De Castro S; Toni D; Sacchetti ML; Biraschi F; Prencipe M; Fiorelli M J Neurol Sci; 2007 Sep; 260(1-2):139-42. PubMed ID: 17512951 [TBL] [Abstract][Full Text] [Related]
26. Plasma Brain Natriuretic Peptide is a Marker of Prognostic Functional Outcome in Non-Cardioembolic Infarction. Kawase S; Kowa H; Suto Y; Fukuda H; Kusumi M; Nakayasu H; Nakashima K J Stroke Cerebrovasc Dis; 2015 Oct; 24(10):2285-90. PubMed ID: 26232887 [TBL] [Abstract][Full Text] [Related]
27. Can Admission BNP Level Predict Outcome After Intravenous Thrombolysis in Acute Ischemic Stroke? Gupta HV; Finlay CW; Jacob S; Raina SK; Lee RW; Hinduja A Neurologist; 2019 Jan; 24(1):6-9. PubMed ID: 30586026 [TBL] [Abstract][Full Text] [Related]
28. NfL (Neurofilament Light Chain) Levels as a Predictive Marker for Long-Term Outcome After Ischemic Stroke. Uphaus T; Bittner S; Gröschel S; Steffen F; Muthuraman M; Wasser K; Weber-Krüger M; Zipp F; Wachter R; Gröschel K Stroke; 2019 Nov; 50(11):3077-3084. PubMed ID: 31537188 [TBL] [Abstract][Full Text] [Related]
29. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Montaner J; Perea-Gainza M; Delgado P; Ribó M; Chacón P; Rosell A; Quintana M; Palacios ME; Molina CA; Alvarez-Sabín J Stroke; 2008 Aug; 39(8):2280-7. PubMed ID: 18535284 [TBL] [Abstract][Full Text] [Related]
30. Elevated plasma brain natriuretic peptide levels independent of heart disease in acute ischemic stroke: correlation with stroke severity. Tomita H; Metoki N; Saitoh G; Ashitate T; Echizen T; Katoh C; Fukuda M; Yasujima M; Osanai T; Okumura K Hypertens Res; 2008 Sep; 31(9):1695-702. PubMed ID: 18971547 [TBL] [Abstract][Full Text] [Related]
31. Brain Natriuretic Peptide and Particular Left Ventricle Segment Asynergy Associated with Cardioembolic Stroke from Old Myocardial Infarction. Hosomi N; Yoshimoto T; Kanaya Y; Neshige S; Hara N; Himeno T; Kono R; Takeshima S; Takamatsu K; Ota T; Miyamoto Y; Yasuda K; Shimoe Y; Ota T; Kuriyama M; Matsumoto M J Stroke Cerebrovasc Dis; 2016 May; 25(5):1165-1171. PubMed ID: 26922130 [TBL] [Abstract][Full Text] [Related]
32. Predictive value of plasma B-type natriuretic peptide for ischemic stroke: a community-based longitudinal study. Takahashi T; Nakamura M; Onoda T; Ohsawa M; Tanno K; Itai K; Sakata K; Sakuma M; Tanaka F; Makita S; Yoshida Y; Ogawa A; Kawamura K; Okayama A Atherosclerosis; 2009 Nov; 207(1):298-303. PubMed ID: 19497572 [TBL] [Abstract][Full Text] [Related]
33. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385 [TBL] [Abstract][Full Text] [Related]
34. Accurate etiology diagnosis in patients with stroke and atrial fibrillation: A role for brain natriuretic peptide. Sakamoto Y; Nito C; Nishiyama Y; Suda S; Matsumoto N; Aoki J; Shimoyama T; Kanamaru T; Suzuki K; Go Y; Mishina M; Kimura K J Neurol Sci; 2019 May; 400():153-157. PubMed ID: 30953905 [TBL] [Abstract][Full Text] [Related]
35. [Prognostic value of N terminal pro B type natriuretic peptide in critically ill patients]. Li ZH; Xiao J; Li JZ Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Mar; 23(3):179-82. PubMed ID: 21366951 [TBL] [Abstract][Full Text] [Related]
36. The prognostic role of brain natriuretic peptides in hemodialysis patients. Naganuma T; Sugimura K; Wada S; Yasumoto R; Sugimura T; Masuda C; Uchida J; Nakatani T Am J Nephrol; 2002; 22(5-6):437-44. PubMed ID: 12381941 [TBL] [Abstract][Full Text] [Related]
37. Brain natriuretic peptide: a relevant marker to rule out delayed atrial fibrillation in stroke patient. Suissa L; Bresch S; Lachaud S; Mahagne MH J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e103-10. PubMed ID: 23010631 [TBL] [Abstract][Full Text] [Related]
38. Ability of NT-pro-BNP to Diagnose Cardioembolic Etiology in Patients with Acute Ischemic Stroke. Okada Y; Terakawa Y; Murata T; Nakamura K; Shimotake K; Murata H; Ohata K Osaka City Med J; 2016 Dec; 62(2):95-102. PubMed ID: 30721584 [TBL] [Abstract][Full Text] [Related]
39. Usefulness of N-terminal pro-brain natriuretic peptide to predict postoperative cardiac complications and long-term mortality after emergency lower limb orthopedic surgery. Chong CP; Ryan JE; van Gaal WJ; Lam QT; Sinnappu RN; Burrell LM; Savige J; Lim WK Am J Cardiol; 2010 Sep; 106(6):865-72. PubMed ID: 20816130 [TBL] [Abstract][Full Text] [Related]
40. BNP but Not s-cTnln is associated with cardioembolic aetiology and predicts short and long term prognosis after cerebrovascular events. Nigro N; Wildi K; Mueller C; Schuetz P; Mueller B; Fluri F; Christ-Crain M; Katan M PLoS One; 2014; 9(7):e102704. PubMed ID: 25072816 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]